Labs / CDMO: development & manufacturing

AltPep
Seattle, WA, United States · altpep.com
GMP
AltPep develops disease-modifying treatments and detection tools for amyloid diseases. Its lead programs focus on Alzheimer’s and Parkinson’s disease, with early detection and treatment programs based in Seattle, Washington.
They take quote requests by email.
What they offer
Therapeutics development
Develops α-sheet-targeting peptide therapeutics intended to detect and neutralize toxic soluble oligomers in amyloid diseases.
Diagnostics development
Develops highly sensitive blood tests intended to aid in the detection of amyloid diseases.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Oligonucleotide
- Assays and studies
- blood tests
- Therapeutic areas
- amyloid diseases, Alzheimer’s disease, Parkinson’s disease
- Sites
- Seattle, USA
- Address
- 1150 Eastlake Avenue E., Suite 800 Seattle, WA 98109
- Founded
- 2020
Public records
- CLIA
- 50D2225744
- CMS CLIA laboratory
- 50D2225744 · SEATTLE source
Similar labs. Aurigene Pharmaceutical Services, Sai Life, ARSI Canada Inc, Esco Aster
Found in a contract services directory. Listing built from altpep.com. Work here? Claim this listing.